Aceclofenac: Side Effects, Uses & Monitoring
INDICATIONS CLANZA CR is indicated for Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism.
- Data source
- FDA labeling via NIH DailyMed (label 8a023942…)
- Label version
- current
- Last reviewed
- 2026
Reported adverse reactions
Reactions listed in current FDA labeling, with the highest frequency reported across summarized placebo-controlled trials.
No structured frequency data available in current labeling. Consult the official label.
Labeled uses (from FDA prescribing information)
INDICATIONS CLANZA CR is indicated for Rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and periarthritis of scapulohumerous, lumbago, ischiadynia, pain caused by nonaticular rheutism.
Conditions associated with Aceclofenac in labeling
Ankylosing Spondylitis
A chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing back pain and stif...
Osteoarthritis
The most common form of arthritis, caused by wear and tear of joint cartilage, leading to pain, stiffness, and...
Rheumatoid Arthritis
A chronic autoimmune disease causing inflammation of joints, leading to pain, swelling, stiffness, and joint d...
Frequently Asked Questions
What is Aceclofenac used for?
FDA labeling lists the approved uses shown above under "Labeled uses." This summary is informational; only a qualified prescriber can determine whether a medication is appropriate for you.
What are the most commonly reported side effects of Aceclofenac?
Current labeling for this ingredient does not include a structured frequency table that we can reproduce. Review the official label linked below.
Does Aceclofenac require lab monitoring?
Monitoring needs vary. Ask your healthcare provider whether any lab tests apply while taking Aceclofenac.
Where does this information come from?
All clinical facts on this page were extracted from the current FDA-registered product labeling for this ingredient, published by manufacturers through NIH DailyMed. See the source link below.
Medical disclaimer: Educational content extracted from public FDA labeling. Not medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.